3¿ù 14ÀÏ ROOM A |
||
½Ã°£ | ¼¼¼Ç | ÁÂÀå/¿¬ÀÚ |
8:30-9:30 | Symposium 2: Thyroid Cancer Survivorship | °È£Ã¶(Àü³²ÀÇ´ë ³»°ú) Á¤À¯¼®(±¹¸³¾Ï¼¾ÅÍ À̺ñÀÎÈÄ°ú) |
8:30-8:45 | CV and Bone Health of Thyroid Cancer Survivor | ½Åµ¿¿í(¼º±Õ°üÀÇ´ë °¡Á¤ÀÇÇаú) |
8:45-9:00 | Psycho-Oncological Care for Thyroid Cancer Patients | Á¤¼®ÈÆ(¿ï»êÀÇ´ë Á¤½Å°ú) |
9:00-9:15 | Successful managenent of skin manifestation associated with thyroid cancer and thyroidectomy | ±èÁöÈñ(¿¬¼¼ÀÇ´ë ÇǺΰú) |
9:15-9:30 | Sialadenitis and Vocal Function in Patients with Thyroid Cancer | À¯Ã¢È¯(±¹¸³¾Ï¼¾ÅÍ À̺ñÀÎÈÄ°ú) |
9:40-10:40 | Symposium 3: New Insight from Immunity to Thyroid Cancer | ÀÌÀçÅÂ(°æºÏÀÇ´ë ÇÙÀÇÇаú) °íÀ±¿ì(¿¬¼¼ÀÇ´ë À̺ñÀÎÈÄ°ú) |
9:40-10:00 | Immune Landscape of Papillary Thyroid Cancer and Immunotherapeutic Implications | ÃÖÈ«À±(¼¿ïÀÇ´ë ÇÙÀÇÇаú) |
10:00-10:20 | Immune Escape Through Natural Killer (NK) Cell Suppression in Thyroid Cancer | ¹Ú¾Æ¸§(Çѱ¹»ý¸í°øÇבּ¸¿ø) |
10:20-10:40 | Macrophage Effects on Tumor Invasion of Papillary Thyroid Carcinoma | Á¶¼±¿í(¼¿ïÀÇ´ë ³»°ú) |
10:40-11:00 | Coffee Break | |
11:00-12:00 | Plenary Lecture | È«¼ø¿ø(¿¬¼¼ÀÇ´ë º´¸®°ú) |
11:00-12:00 | Difference in Thyroid Pathology Practice Between North America and the Rest of the World | Kennichi Kakudo(Department of Pathology and Thyroid Disease Center, Izumi City General Hospital, Japan) |
12:00-12:30 | ÃÑȸ | |
12:30-13:30 | Luncheon Symposium | ±èÁ¤±¹(°æºÏÀÇ´ë ³»ºÐºñ³»°ú) |
12:30-13:30 | °©»ó¼±Áúȯ¿¡¼ÀÇ metabolic care | ±èº¸Çö(ºÎ»êÀÇ´ë ³»°ú) |
13:30-14:10 | ¹ü»ê Çмú»ó | ÀÌ°´ë(°í½ÅÀÇ´ë À̺ñÀÎÈÄ°ú(KTA ȸÀå)) |
13:30-14:10 | TBD | Á¤Á¾±æ(¿©¼öÀü³²º´¿ø ¿Ü°ú) |
14:15-15:15 | Symposium 4: Recurrent/ Persistent Advanced Differentiated Thyroid Cancer | ¼ÒÀÇ¿µ(¾ÆÁÖ´ë ¿Ü°ú) Á¤±¤À±(°í·Á´ë À̺ñÀÎÈÄ°ú) |
14:15-14:35 | Radiological Characteristics of Recurrent/Persistent Well-Differentiated Thyroid Cancer Based on Computed Tomographic Analysis | ±èÁöÈÆ(¼¿ïÀÇ´ë ¿µ»óÀÇÇаú) |
14:35-14:55 | Revision Surgery & Clinical outcome of Recurrent/ Persistent Well-Differentiated Thyroid Cancer | Á¤ÁøÇâ(°æºÏÀÇ´ë ¿Ü°ú) |
14:55-15:15 | RFA for Recurrent/ Persistent Well-Differentiated Thyroid Cancer | ¹éÁ¤È¯(¿ï»êÀÇ´ë ¿µ»óÀÇÇаú) |
15:15-15:35 | Coffee Break | |
15:35-16:35 | Meet the Professor 2 | Á¤Çö°æ(´Ü±¹ÀÇ´ë ³»°ú) |
15:35-16:35 | Interesting case of Graves' disease | Á¤±â¿í(¿ï»êÀÇ´ë ¿Ü°ú) ÀÓµ¿ÁØ(°¡Å縯ÀÇ´ë ³»°ú) ¾Èº´Ã¶(°æºÏÀÇ´ë ÇÙÀÇÇаú) ±è¼±¿í(¼º±Õ°üÀÇ´ë ³»°ú) |
16:40-17:40 | Topic Highlight | ¾Èº´Ã¶(°æºÏÀÇ´ë ÇÙÀÇÇаú) ³²±âÇö(¿¬¼¼ÀÇ´ë ¿Ü°ú) |
17:40 | Æóȸ ¹× ½Ã»ó½Ä | |
3¿ù 14ÀÏ ROOM B |
||
½Ã°£ | ¼¼¼Ç | ÁÂÀå/¿¬ÀÚ |
08:30-09:30 | Free Paper 3 | ±èÀÎÁÖ(ºÎ»êÀÇ´ë ³»°ú) Á¤¼Ò·É(°¡Å縯ÀÇ´ë ¿µ»óÀÇÇаú) |
9:40-10:40 | Free Paper 4 | Á¶¿µ¼®(¿¬¼¼ÀÇ´ë ³»°ú) À̼¼¿µ(Áß¾ÓÀÇ´ë À̺ñÀÎÈÄ°ú) |
10:40-11:00 | Coffee Break | |
11:00-12:00 | °£È£»ç Session: | ÃÖÁØ¿µ(¼¿ïÀÇ´ë ¿Ü°ú) |
11:00-11:20 | °©»ó¼± ¼ö¼ú¿¡ ´ëÇÑ ÀÌÇØ ¹× ¼ö¼ú Àü ÈÄ È¯ÀÚ °ü¸® | ÀÌÀ¯¹Ì(¿ï»êÀÇ´ë ¿Ü°ú) |
11:20-11:40 | ¹æ»ç¼º ¿ä¿Àµå Ä¡·á Àü ÈÄ È¯ÀÚÀÇ °ü¸® | ¸¶°æÈñ(°æºÏ´ëÇб³ º´¿ø Àü¹®°£È£»ç) |
11:40-12:00 | °©»ó¼±¾Ï ȯÀÚÀÇ Àå±â ÃßÀû °üÂû ¹æħ | ÃÖÀ±¹Ì(ÇѸ²ÀÇ´ë ³»°ú) |
15:30-15:50 | Coffee Break | |
14:15-15:15 | Symposium 5: How to deal with PTMC in Radiology | ³ªµ¿±Ô(°¸ª¾Æ»êº´¿ø ¿µ»óÀÇÇаú) ¼ºÁø¿ë(´ë¸²¼º¸ðº´¿ø ¿µ»óÀÇÇаú) |
14:15-14:35 | Current stance on active surveillance of low-risk PTMC | ¼Û¿µ±â(¿ï»êÀÇ´ë ³»°ú) |
14:35-14:55 | Role of Thyroid US and CT in active surveillance of low-risk PTMC | ¾ÈÇý½Å(Áß¾ÓÀÇ´ë ¿µ»óÀÇÇаú) |
14:55-15:15 | Interventional management of low-risk PTMC | ÇÏÀºÁÖ(¾ÆÁÖÀÇ´ë ¿µ»óÀÇÇаú) |
15:35-16:35 | ¿¬±¸À§¿øȸ:New approach in cancer reaserch | ¼Û¹ÎÈ£(Ãæ³²ÀÇ´ë ³»°ú) |
15:35-16:05 | Multi-Omics Approaches for Cancer Study | À̼¼¹Î(UNIST) |
16:05-16:35 | Cellular Heterogeneity, Cellular Plasticity, and Single-Cell Genomics | ±èÁ¾°æ(DGIST) |
17:40 | Æóȸ ¹× ½Ã»ó½Ä |